Activated protein C resistance during in vitro fertilization treatment

被引:10
作者
Curvers, J
Nienhuis, SJ
Nap, AW
Hamulyák, K
Evers, JLH
Rosing, J
机构
[1] Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands
[2] Univ Limburg, Acad Hosp Maastricht, Dept Obstet & Gynaecol, Maastricht, Netherlands
[3] Univ Limburg, Acad Hosp Maastricht, Dept Hematol, Maastricht, Netherlands
关键词
APC resistance; IVF treatment; estrogens; oral contraceptives; venous thrombosis;
D O I
10.1016/S0301-2115(00)00495-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Acquired resistance to the anticoagulant action of activated protein C (APC) has been proposed To explain the increased risk of venous thrombosis associated with pregnancy, hormone replacement therapy and the use of oral contraceptives, Tn this study, we have investigated whether the hormonal changes induced during in vitro fertilization (IVF) treatment are also associated with acquired APC resistance. Twenty-nine women, who were planned for an IVF cycle, donated blood at four time points during treatment, i.e. at baseline, down-regulation, hyperstimulation and luteal support. Tn the plasma samples, APC sensitivity ratios (APCsr) and the levels of progesteron and estradiol were measured. The changes in plasma concentrations of hormones were in accordance with literature. The APCsr increased significantly during hyperstimulation and remained high during luteal support. The extent of APC resistance occurring during IVF treatment was comparable to that observed during the use of second generation OC and was less pronounced than that occurring during pregnancy. The change in estradiol between baseline and hyperstimulation correlated with the change in APCsr. Although this suggests that plasma estrogen levels are an important determinant For acquired APC resistance. it remains to be established a which plasma proteins are responsible for estrogen-induced APC resistance. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:222 / 224
页数:3
相关论文
共 32 条
[1]   CHANGES INDUCED IN SERUM-PROTEIN PROFILES BY OVARIAN STIMULATION DURING INVITRO FERTILIZATION EMBRYO TRANSFER TREATMENT - A COMPARISON BETWEEN CONCEPTION AND NON-CONCEPTION CYCLES [J].
ANDERSEN, CY ;
WESTERGAARD, LG ;
TEISNER, B ;
BYSKOV, AG ;
ZIEBE, S ;
HELLEDIE, L ;
PETERSEN, K ;
WESTERGAARD, JG .
HUMAN REPRODUCTION, 1992, 7 (05) :585-591
[2]   RISK OF THROMBOEMBOLISM IN RELATION TO AN IN-VITRO FERTILIZATION PROGRAM - 3 CASE-REPORTS [J].
AUROUSSEAU, MH ;
SAMAMA, MM ;
BELHASSEN, A ;
HERVE, F ;
HUGUES, JN .
HUMAN REPRODUCTION, 1995, 10 (01) :94-97
[3]   ENHANCEMENT BY FACTOR-V LEIDEN MUTATION OF RISK OF DEEP-VEIN THROMBOSIS ASSOCIATED WITH ORAL-CONTRACEPTIVES CONTAINING 3RD-GENERATION PROGESTAGEN [J].
BLOEMENKAMP, KWM ;
ROSENDAAL, FR ;
HELMERHORST, FM ;
BULLER, HR ;
VANDENBROUCKE, JP .
LANCET, 1995, 346 (8990) :1593-1596
[4]   COAGULATION EFFECTS OF ORAL CONTRACEPTION [J].
BONNAR, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 157 (04) :1042-1048
[5]   DO LOWERED FACTOR-VII LEVELS AT EXTREMELY HIGH ENDOGENOUS ESTRADIOL LEVELS PROTECT AGAINST THROMBIN FORMATION [J].
BREMME, K ;
WRAMSBY, H ;
ANDERSSON, O ;
WALLIN, M ;
BLOMBACK, M .
BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (02) :205-210
[6]   Risk of venous thromboembolism in users of hormone replacement therapy [J].
Daly, E ;
Vessey, MP ;
Hawkins, MN ;
Carson, JL ;
Gough, P ;
Marsh, S .
LANCET, 1996, 348 (9033) :977-980
[7]  
FARLEY TMM, 1995, LANCET, V346, P1582
[8]   Postmenopausal hormone therapy increases risk for venous thromboembolic disease - The heart and estrogen/progestin replacement study [J].
Grady, D ;
Wenger, NK ;
Herrington, D ;
Khan, S ;
Furberg, C ;
Hunninghake, D ;
Vittinghoff, E ;
Hulley, S .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) :689-+
[9]   Thrombosis in pregnancy: maternal and fetal issues [J].
Greer, IA .
LANCET, 1999, 353 (9160) :1258-1265
[10]  
HENKENS CMA, 1995, THROMB HAEMOSTASIS, V73, P402